Lamivudine
- Product NDC
- 70518-2070
- 11-digit product format
- 705182070
- Labeler code
- 70518
- Product ID
- 70518-2070_e9ea2353-0251-b2fc-e053-2995a90a94e0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090457
- Marketing category
- ANDA
- Marketing start
- 2019-05-08
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2070 | LAMIVUDINE TABLET, FILM COATED [REMEDYREPACK INC.] | 12 | Legacy NDC | 20250306_196f85ee-da62-40fc-a52e-ffcfb9ed1fc0.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2070-0 | 70518207000 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2070-0) | 2019-05-08 | 0000-00-00 | No | No | Current |